Benzo(a)pyrene disrupts EP300-mediated epigenetic regulation of HSPA1A to alter membrane tension and promote EMT-associated migration and invasion in lung cancer cells
Year: 2026
Type: article
Abstract: Benzo(a)pyrene (B(a)P), a prominent environmental carcinogen, is known to promote lung cancer progression; however, its underlying mechanistic pathways remain poorly defined. Here, we identify the EP300–H2BK5ac epigenetic axis as a key regulator of membrane surface tension and epithelial–mesenchymal transition (EMT) in lung cancer cells under B(a)P exposure. Using A549 and SW900 cells, we demonstrate that B(a)P treatment induces a dose-dependent reduction in membrane tension and promotes EMT, migration, and invasion. Mechanistically, B(a)P downregulates EP300 expression, leading to decreased H2BK5ac acetylation and impaired binding of H2BK5ac to the promoter of the endocytosis-related gene HSPA1A, as revealed by co-immunoprecipitation and ChIP-qPCR. EP300 knockdown mimics these effects, enhancing malignant behaviors, whereas EP300 overexpression restores H2BK5ac levels, increases HSPA1A expression, and suppresses B(a)P-induced phenotypes. Notably, HSPA1A overexpression in EP300-deficient cells partially rescues membrane tension and reverses EMT progression. These findings uncover a previously unrecognized EP300–H2BK5ac–HSPA1A regulatory pathway that links environmental exposure to biomechanical and epigenetic remodeling in lung cancer. Targeting this axis may offer new strategies to mitigate B(a)P-driven metastasis. H2BK5ac-HSPA1A Axis in Regulating Membrane Tension, EMT, and Lung Cancer Progression under B(a)P Exposure. B(a)P suppresses EP300 expression, leading to reduced H2BK5ac acetylation and downregulation of endocytosis-related genes (HSPA1A, HSPA1B, HSPA1L, AP2S1), resulting in decreased membrane tension and enhanced epithelial–mesenchymal transition (EMT), migration, and invasion. EP300 overexpression reverses these effects by restoring H2BK5ac and HSPA1A expression, elevating HSP70 levels, increasing membrane tension, and suppressing EMT and cell motility. Conversely, EP300 knockdown exacerbates B(a)P-induced effects, while HSPA1A overexpression in EP300-deficient cells partially rescues HSP70 expression and membrane tension, attenuating EMT and invasiveness. Arrows indicate directional changes in phenotypes across experimental conditions. • Benzo(a)pyrene reduces membrane tension and induces EMT in lung cancer cells. • B(a)P disrupts EP300–H2BK5ac signaling and enhances cancer cell motility. • HSPA1A acts as a key downstream effector of the EP300–H2BK5ac axis. • Restoring EP300 or HSPA1A reverses membrane tension loss and EMT. • An epigenetic–biophysical axis links B(a)P exposure to malignant behavior.
Authors: Manqing Li, Xiumei Xing, Jie Jiang, Shicheng Liao, Chao Wang, Haojia Ma, Zhjie Wu, Yue Wang, Ni Xie, Zhuoying Zeng
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,650
Awards: G7784506556, G8728916211
OpenAlex ID: W7128164029
